Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19?
作者信息
Vakil-Gilani Kiana, O'Rourke Kenneth
机构信息
Department of Rheumatology, Maine Medical Center, Portland, ME, USA.
出版信息
Clin Rheumatol. 2020 Jul;39(7):2067-2068. doi: 10.1007/s10067-020-05184-3. Epub 2020 May 30.
Abstract
摘要
相似文献
1
Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19?
Clin Rheumatol. 2020 Jul;39(7):2067-2068. doi: 10.1007/s10067-020-05184-3. Epub 2020 May 30.
2
COVID-19 and rheumatology: is shielding really necessary?
Br J Hosp Med (Lond). 2020 Jun 2;81(6):1-3. doi: 10.12968/hmed.2020.0284. Epub 2020 Jun 3.
3
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic.
Rheumatology (Oxford). 2020 Sep 1;59(9):2644-2646. doi: 10.1093/rheumatology/keaa388.
4
How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion.
Autoimmun Rev. 2020 Jul;19(7):102574. doi: 10.1016/j.autrev.2020.102574. Epub 2020 May 5.
5
National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
RMD Open. 2020 Sep;6(2). doi: 10.1136/rmdopen-2020-001332.
6
How to manage rheumatic patients during the coronavirus pandemic.
Panminerva Med. 2020 Sep;62(3):176-177. doi: 10.23736/S0031-0808.20.03935-X. Epub 2020 Apr 28.
7
[Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic].
Z Rheumatol. 2020 May;79(4):385-388. doi: 10.1007/s00393-020-00799-y.
8
Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases.
Ann Rheum Dis. 2020 Dec;79(12):1659-1661. doi: 10.1136/annrheumdis-2020-218054. Epub 2020 Jun 30.
9
COVID-19 and smoking: a high-risk association.
Cad Saude Publica. 2020;36(5):e00072020. doi: 10.1590/0102-311x00072020. Epub 2020 May 18.
10
Covid-19 and Kidney Transplantation.
N Engl J Med. 2020 Jun 18;382(25):2475-2477. doi: 10.1056/NEJMc2011117. Epub 2020 Apr 24.
引用本文的文献
1
Protein Posttranslational Signatures Identified in COVID-19 Patient Plasma.
Front Cell Dev Biol. 2022 Feb 11;10:807149. doi: 10.3389/fcell.2022.807149. eCollection 2022.
2
Neuromuscular Diseases Care in the Era of COVID-19.
Front Neurol. 2020 Nov 26;11:588929. doi: 10.3389/fneur.2020.588929. eCollection 2020.
本文引用的文献
1
Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York.
N Engl J Med. 2020 Jul 2;383(1):85-88. doi: 10.1056/NEJMc2009567. Epub 2020 Apr 29.
2
Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets.
Clin Rheumatol. 2020 Jul;39(7):2055-2062. doi: 10.1007/s10067-020-05073-9. Epub 2020 Apr 10.
3
Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients.
Clin Immunol. 2020 Jun;215:108410. doi: 10.1016/j.clim.2020.108410. Epub 2020 Apr 8.
4
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.
N Engl J Med. 2020 Apr 23;382(17):e38. doi: 10.1056/NEJMc2007575. Epub 2020 Apr 8.
5
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy.
J Autoimmun. 2020 May;109:102442. doi: 10.1016/j.jaut.2020.102442. Epub 2020 Apr 2.
6
Baricitinib for COVID-19: a suitable treatment?
Lancet Infect Dis. 2020 Sep;20(9):1012-1013. doi: 10.1016/S1473-3099(20)30262-0. Epub 2020 Apr 3.
7
The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic.
Nat Rev Rheumatol. 2020 Jun;16(6):293-294. doi: 10.1038/s41584-020-0418-0.
8
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.
Ann Rheum Dis. 2020 May;79(5):667-668. doi: 10.1136/annrheumdis-2020-217424. Epub 2020 Apr 2.
9
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic.
Liver Transpl. 2020 Jun;26(6):832-834. doi: 10.1002/lt.25756. Epub 2020 Apr 24.
10
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
Zotero 插件